Concentricolide, an anti-HIV agent from the ascomycete Daldinia concentrica | |
Qin, XD; Dong, ZJ![]() | |
2006 | |
发表期刊 | HELVETICA CHIMICA ACTA
![]() |
ISSN | 0018-019X |
卷号 | 89期号:1页码:127-133 |
摘要 | A novel benzofuran lactone, named concentricolide (=rel-(6R)-6-ethylbenzo[2.1-b:3,4-c']difuran-8(6H)-one; 1), was isolated along with four known compounds (friedelin, cytochalasin L-696.474, armillaramide, and russulamide) from the fruiting bodies of the xylariaceous ascomycete Daldinia concentrica. The structure of I was established by spectroscopic methods and X-ray crystallographic analysis. Its anti-HIV-1 activity was tested. Results showed that 1 inhibited HIV-1 induced cytopathic effects. The EC50 value was 0.31 mu g/ml. The therapeutic index (TI) was 247. Concentricolide exhibited the blockage (EC50 0.83 mu g/ml) on syncytium formation between HIV-1 infected cells and normal cells. |
关键词 | Fruiting Bodies Fungus Derivatives |
学科领域 | Chemistry ; Multidisciplinary |
收录类别 | SCI ; IC |
语种 | 英语 |
WOS记录号 | WOS:000234988100014 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/1609 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Peoples R China 2.Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Peoples R China 3.Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China |
推荐引用方式 GB/T 7714 | Qin, XD,Dong, ZJ,Liu, JK,et al. Concentricolide, an anti-HIV agent from the ascomycete Daldinia concentrica[J]. HELVETICA CHIMICA ACTA,2006,89(1):127-133. |
APA | Qin, XD.,Dong, ZJ.,Liu, JK.,Yang, LM.,Wang, RR.,...&Zheng, QT.(2006).Concentricolide, an anti-HIV agent from the ascomycete Daldinia concentrica.HELVETICA CHIMICA ACTA,89(1),127-133. |
MLA | Qin, XD,et al."Concentricolide, an anti-HIV agent from the ascomycete Daldinia concentrica".HELVETICA CHIMICA ACTA 89.1(2006):127-133. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
201111040013.pdf(420KB) | 开放获取 | -- | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论